Literature DB >> 85519

Electroencephalography in brain edema (127 cases of brain tumor investigated by cranial computerized tomography).

J L Gastaut, B Michel, S S Hassan, M Cerda, L Bianchi, H Gastaut.   

Abstract

Cranial computerized tomography (CCT) in permitting visualization of cerebral edema in live patients, allows for the first time valid studies concerning the role of reactional edema in the generation of EEG abnormalities related to expanding processes. The authors analyze the results of EEG and CCT in 127 patients presenting cerebral tumor(s), 84 of which were accompanied by reactional edema. The study leads to the conclusion (also demonstrated by certain animal work) that edema per se is only rarely responsible (9.5%) for the EEG abnormalities.

Entities:  

Mesh:

Year:  1979        PMID: 85519     DOI: 10.1016/0013-4694(79)90200-1

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  5 in total

1.  Corticosteroid therapy of experimental tumour oedema.

Authors:  Y Matsuoka; K A Hossmann
Journal:  Neurosurg Rev       Date:  1981       Impact factor: 3.042

2.  Experimental transplantation gliomas in the adult cat brain. 2. Pathophysiology and magnetic resonance imaging.

Authors:  K A Hossmann; J Szymas; K Seo; J Assheuer; S Krajewski
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  The effects of malignant glioma on the EEG and seizure thresholds: an experimental study.

Authors:  A Beaumont; M Clarke; I R Whittle
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  Full Recovery From Cocaine-Induced Toxic Leukoencephalopathy: Emphasizing the Role of Neuroinflammation and Brain Edema.

Authors:  Edward C Mader; Alexander B Ramos; Roberto A Cruz; Lionel A Branch
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

5.  Clinical and imaging correlates of EEG patterns in hospitalized patients with encephalopathy.

Authors:  Raoul Sutter; Robert D Stevens; Peter W Kaplan
Journal:  J Neurol       Date:  2012-11-30       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.